Multiple Myeloma in the non-transplant setting (1/2)
Multiple Myeloma in the non-transplant setting (1/2)
International Myeloma Workshop highlights and ongoing IMF studies
Lenalidomide and dexamethasone to delay progression of smouldering multiple myeloma
Flexible dosing of bortezomib for multiple myeloma
Tailoring therapy in elderly myeloma patients
Lenalidomide survival benefit as continuous therapy for multiple myeloma
Oncoproteins and genes involved in the chromosomal translocations of APL
The Cancer Genome Atlas (TCGA)
AACR 2011: New Phase I targeted cancer drugs
Psycho-social aspects of treating elderly patients: Expert roundtable
Management of elderly lymphoma patients: Expert Roundtable
Treatment of elderly multiple myeloma patients: Expert Roundtable